Skip to main content

Advertisement

Table 1 Comparison of fatty acid compositions in healthy persons and patients (%, X ± S)

From: Changes in erythrocyte polyunsaturated fatty acids and plasma eicosanoids level in patients with asthma

  Healthy group (n = 31) Patients group (n = 31)
C14:0 0.30 ± 0.25 0.65 ± 0.48**
C15:0 0.10 ± 0.04 0.17 ± 0.09
C15:1 2.43 ± 0.46 1.95 ± 0.44**
C16:0 17.76 ± 0.83 19.74 ± 2.12**
C16:1 0.26 ± 0.12 0.51 ± 0.17**
C18:0 10.26 ± 0.60 10.43 ± 0.69
C18:1 12.14 ± 1.23 14.02 ± 1.96**
C18:2(n-6) 10.69 ± 1.24 10.47 ± 1.99
C18:3(n-3) 0.07 ± 0.02 0.09 ± 0.07
C20:0 0.32 ± 0.05 0.34 ± 0.10
C20:1 0.25 ± 0.05 0.27 ± 0.08
C20:2(n-6) 0.79 ± 0.46 0.30 ± 0.13**
C20:3(n-6) 1.37 ± 0.30 1.45 ± 0.32
C20:4(n-6) 16.52 ± 1.07 15.52 ± 2.12*
C20:5(n-3) 0.64 ± 0.35 0.73 ± 0.41
C22:0 4.86 ± 1.93 4.16 ± 2.74
C22:4(n-6) 2.96 ± 0.54 2.76 ± 0.80
C22:5(n-3) 2.25 ± 0.40 2.18 ± 0.48
C22:6(n-3) 7.57 ± 1.52 4.55 ± 1.87**
C24:0 4.24 ± 1.03 6.21 ± 1.55*
C24:1 4.21 ± 0.70 3.51 ± 1.12**
n-6 32.33 ± 1.57 30.49 ± 3.03**
n-3 10.52 ± 2.05 7.56 ± 2.37**
n-6/n-3 3.21 ± 0.79 4.42 ± 1.33*
AA 16.52 15.52
EPA + DHA 8.21 5.28
AA/(EPA + DHA) 2.01 2.94
SFA 37.84 41.70
MUFA 19.29 20.26
PUFA 42.86 38.05
UFA 62.15 58.31
SFA/UFA 0.61 0.72
  1. Note: *, p < 0.05; **, p < 0.01